Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01234870 · ClinicalTrials.gov registry record · Phase 2
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
A Phase 2 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT01234870 is a Phase 2 study that has completed, run by Northwestern University. The registered enrollment target is 40 participants.
The verdict
NCT01234870, a Phase 2 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the diagnostic performance of fully automated motion corrected (MC) first pass myocardial perfusion MRI, compared to the original non-corrected first pass myocardial perfusion images in a cohort of patients with suspected ischemic heart disease, using coronary angiography as the reference standard. It is expected that this improved comprehensive protocol for cardiac MRI be accurate at detecting significant coronary artery disease and may obviate the need for other more expensive and invasive diagnostic tests currently used.
Interventions
- DRUG Gadolinium
- DRUG Adenosine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01234870
The ClinicalTrials.gov registry entry for NCT01234870 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gadolinium is the first listed.
NCT01234870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01234870 about?
NCT01234870 is a clinical study titled "Comprehensive Evaluation of Ischemic Heart Disease Using MRI". The purpose of the study is to assess the diagnostic performance of fully automated motion corrected (MC) first pass myocardial perfusion MRI, compared to the original non-corrected first pass myocardial perfusion images in a cohort of patients with suspected ischemic heart disease, using coronary a...
What is the current status of trial NCT01234870?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2010-06. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01234870?
The interventions under investigation include: Gadolinium (DRUG), Adenosine (DRUG).
Who is sponsoring clinical trial NCT01234870?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.